181 related articles for article (PubMed ID: 19841950)
1. Bloodless cancer treatment results of patients who do not want blood transfusion: single center experience of 77 cases.
Oh SY; Kim SH; Kwon HC; Lee S; Kim KH; Kwon KA; Lee JH; Lee KY; Kim HJ
Support Care Cancer; 2010 Oct; 18(10):1341-6. PubMed ID: 19841950
[TBL] [Abstract][Full Text] [Related]
2. Pancreatic resections in patients who refuse blood transfusions. The application of a perioperative protocol for a true bloodless surgery.
De Bellis M; Girelli D; Ruzzenente A; Bagante F; Ziello R; Campagnaro T; Conci S; Nifosì F; Guglielmi A; Iacono C
Pancreatology; 2020 Oct; 20(7):1550-1557. PubMed ID: 32950387
[TBL] [Abstract][Full Text] [Related]
3. [Mortality after high-risk surgery in Jehovah's Witness patients].
Habler O; Thörner M; Schmidt C; Hofmann P; Döbert U; Höhler M; Klingler S; Moog S; Oehme A; Schäufele M; Wege C; Voß B
Anaesthesist; 2019 Jul; 68(7):444-455. PubMed ID: 31236704
[TBL] [Abstract][Full Text] [Related]
4. Pancreas and liver resection in Jehovah's Witness patients: feasible and safe.
Konstantinidis IT; Allen PJ; D'Angelica MI; DeMatteo RP; Fischer ME; Grant F; Fong Y; Kingham TP; Jarnagin WR
J Am Coll Surg; 2013 Dec; 217(6):1101-7. PubMed ID: 23880361
[TBL] [Abstract][Full Text] [Related]
5. Short-term outcome of cardiac surgery under cardiopulmonary bypass in patients who refuse transfusion: a controlled study.
Reyes Garcia A; Vega González G; Andino Ruiz R
J Cardiovasc Surg (Torino); 2018 Oct; 59(5):729-736. PubMed ID: 29616523
[TBL] [Abstract][Full Text] [Related]
6. Risk-adjusted clinical outcomes in patients enrolled in a bloodless program.
Frank SM; Wick EC; Dezern AE; Ness PM; Wasey JO; Pippa AC; Dackiw E; Resar LM
Transfusion; 2014 Oct; 54(10 Pt 2):2668-77. PubMed ID: 24942198
[TBL] [Abstract][Full Text] [Related]
7. Jehovah's Witnesses and cardiac surgery: a single institution's experience.
McCartney S; Guinn N; Roberson R; Broomer B; White W; Hill S
Transfusion; 2014 Oct; 54(10 Pt 2):2745-52. PubMed ID: 24809815
[TBL] [Abstract][Full Text] [Related]
8. Bloodless Orthotopic Heart Transplantation in a Jehovah's Witness.
Dallas T; Welsby I; Bottiger B; Milano C; Daneshmand M; Guinn N
A A Case Rep; 2015 May; 4(10):140-2. PubMed ID: 25974419
[TBL] [Abstract][Full Text] [Related]
9. "Bloodless" Neurosurgery Among Jehovah's Witnesses: A Comparison with Matched Concurrent Controls.
Hardesty DA; Doerfler S; Sandhu S; Whitmore RG; Ford P; Rushton S; LeRoux PD
World Neurosurg; 2017 Jan; 97():132-139. PubMed ID: 27641256
[TBL] [Abstract][Full Text] [Related]
10. Optimizing Safety and Success: The Advantages of Bloodless Cardiac Surgery. A Systematic Review and Meta-Analysis of Outcomes in Jehovah's Witnesses.
Gemelli M; Italiano EG; Geatti V; Addonizio M; Cao I; Dimagli A; Dokollari A; Tarzia V; Gallo M; Ferrari E; Slaughter MS; Gerosa G
Curr Probl Cardiol; 2024 Jan; 49(1 Pt B):102078. PubMed ID: 37716536
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive blood conservation program in a new congenital cardiac surgical program allows bloodless surgery for the Jehovah Witness and a reduction for all patients.
Olshove V; Berndsen N; Sivarajan V; Nawathe P; Phillips A
Perfusion; 2018 Apr; 33(3):194-202. PubMed ID: 28985692
[TBL] [Abstract][Full Text] [Related]
12. Peri-operative blood management of Jehovah's Witnesses undergoing cytoreductive surgery for advanced ovarian cancer.
Palaia I; Caruso G; Di Donato V; Perniola G; Ferrazza G; Panzini E; Scudo M; Di Pinto A; Muzii L; Panici PB
Blood Transfus; 2022 Mar; 20(2):112-119. PubMed ID: 35244533
[TBL] [Abstract][Full Text] [Related]
13. Intraoperative Anemia and Single Red Blood Cell Transfusion During Cardiac Surgery: An Assessment of Postoperative Outcome Including Patients Refusing Blood Transfusion.
Hogervorst EK; Rosseel PM; van de Watering LM; Brand A; Bentala M; van der Bom JG; van der Meer NJ
J Cardiothorac Vasc Anesth; 2016 Apr; 30(2):363-72. PubMed ID: 26809765
[TBL] [Abstract][Full Text] [Related]
14. Mid-term clinical outcomes in cardiac surgery of Jehovah's witnesses.
Pompei E; Tursi V; Guzzi G; Vendramin I; Ius F; Muzzi R; Auci E; Badano LP; Livi U
J Cardiovasc Med (Hagerstown); 2010 Mar; 11(3):170-4. PubMed ID: 19934767
[TBL] [Abstract][Full Text] [Related]
15. Long-term survival and quality of life in Jehovah's witnesses after cardiac surgery: a case control study.
Wauthy P; Pierrakos C; Chebli L; Tortora R
BMC Cardiovasc Disord; 2019 Mar; 19(1):73. PubMed ID: 30922241
[TBL] [Abstract][Full Text] [Related]
16. Eight-year experience of bloodless surgery at a tertiary care hospital in Korea.
Jo KI; Shin JW; Choi TY; Park YJ; Youm W; Kim MJ
Transfusion; 2013 May; 53(5):948-54. PubMed ID: 22924834
[TBL] [Abstract][Full Text] [Related]
17. A single-institution experience of performing bloodless transplant in Jehovah's Witness patients.
Coltoff A; Shreenivas A; Afshar S; Steinberg A
Hematol Oncol Stem Cell Ther; 2019 Mar; 12(1):44-49. PubMed ID: 30605629
[TBL] [Abstract][Full Text] [Related]
18. Outcomes in cardiac surgery in 500 consecutive Jehovah's Witness patients: 21 year experience.
Vaislic CD; Dalibon N; Ponzio O; Ba M; Jugan E; Lagneau F; Abbas P; Olliver Y; Gaillard D; Baget F; Sportiche M; Chedid A; Chaoul G; Maribas P; Dupuy C; Robine B; Kasanin N; Michon H; Ruat JM; Habis M; Bouharaoua T
J Cardiothorac Surg; 2012 Sep; 7():95. PubMed ID: 23013647
[TBL] [Abstract][Full Text] [Related]
19. Patterns of care in Jehovah's Witnesses patients with solid tumours and lymphoma.
Chang Lee R; Sukumaran S; Koczwara B; Woodman R; Kichenadasse G; Roy A; Vatandoust S; Karapetis C
Cancer Rep (Hoboken); 2019 Apr; 2(2):e1148. PubMed ID: 32721085
[TBL] [Abstract][Full Text] [Related]
20. Antineoplastic chemotherapy in Jehovah's Witness patients with acute myelogenous leukemia refusing blood products - a matched pair analysis.
Wilop S; Osieka R
Hematology; 2018 Jul; 23(6):324-329. PubMed ID: 29212421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
